FHI, Federatie van technologiebranches

Branche

Laboratorium Technologie

We’re building on a legacy of innovation and commitment to revolutionizing health science. Working together, we’ve already impacted health worldwide in many ways, including:

700 peer-reviewed publications describing our TB test as demonstrating excellent performance in a wide variety of settings

Providing workflows that enabled the testing of more than 75 million individuals for COVID-19

Introducing over 1,500 new antibodies, kits, and reagents annually for life science research
Supplying more than two million scientists across pharma, biotech, and academia with Revvity's software solutions
Screening 40 million babies annually for life-threatening diseases across 110 countries

As a team of more than 11,000 employees across 190 countries, we offer both scale and agility. United, we can deliver custom, complete solutions from discovery to development, and diagnosis to cure.

Combined with our rapidly growing strength in automation, productivity, and workflow, we are uniquely positioned to accelerate health science innovation from bench to bedside. And this is just the beginning.

Our specialized areas of focus include translational multi-omics technologies, biomarker identification, imaging, prediction, screening and diagnosis, detection, informatics, and more.

Contact

Rigaweg 22 9723 TH Groningen

Naar de website

Evenementen

WoTS

Neem direct contact op

Name

Dit veld is bedoeld voor validatiedoeleinden en moet niet worden gewijzigd.

Naam

Voornaam Achternaam

Bedrijfsnaam(Vereist)

E-mailadres(Vereist)

Je vraag/opmerking

Telefoon

Dit veld is verborgen bij het bekijken van het formulier

E-mailadres(Vereist)

CAPTCHA

Revvity

Impossible is inspiration

If they say “impossible,” we say “challenge accepted.” At Revvity, we fearlessly face tomorrow’s unknowns for a healthier humankind.

We’re building on a legacy of innovation and commitment to revolutionizing health science. Working together, we’ve already impacted health worldwide in many ways, including:

Introducing over 1,500 new antibodies, kits, and reagents annually for life science research

Supplying more than two million scientists across pharma, biotech, and academia with Revvity's software solutions

Screening 40 million babies annually for life-threatening diseases across 110 countries

As a team of more than 11,000 employees across 190 countries, we offer both scale and agility. United, we can deliver custom, complete solutions from discovery to development, and diagnosis to cure.

Combined with our rapidly growing strength in automation, productivity, and workflow, we are uniquely positioned to accelerate health science innovation from bench to bedside. And this is just the beginning.

Our specialized areas of focus include translational multi-omics technologies, biomarker identification, imaging, prediction, screening and diagnosis, detection, informatics, and more.

Contact

Evenementen

Neem direct contact op

Impossible is inspiration

If they say “impossible,” we say “challenge accepted.” At Revvity, we fearlessly face tomorrow’s unknowns for a healthier humankind.

We’re building on a legacy of innovation and commitment to revolutionizing health science. Working together, we’ve already impacted health worldwide in many ways, including:

Introducing over 1,500 new antibodies, kits, and reagents annually for life science research

Supplying more than two million scientists across pharma, biotech, and academia with Revvity's software solutions

Screening 40 million babies annually for life-threatening diseases across 110 countries

As a team of more than 11,000 employees across 190 countries, we offer both scale and agility. United, we can deliver custom, complete solutions from discovery to development, and diagnosis to cure.

Combined with our rapidly growing strength in automation, productivity, and workflow, we are uniquely positioned to accelerate health science innovation from bench to bedside. And this is just the beginning.

Our specialized areas of focus include translational multi-omics technologies, biomarker identification, imaging, prediction, screening and diagnosis, detection, informatics, and more.

Contact

Evenementen

Neem direct contact op

Supplying more than two million scientists across pharma, biotech, and academia with Revvity's software solutions